VXLLF
Vaxil Bio Ltd

186
Mkt Cap
$301,400.00
Volume
10.00
52W High
$1.75
52W Low
$0.0021
PE Ratio
-6.21
VXLLF Fundamentals
Price
$0.11
Prev Close
$0.085
Open
$0.0226
50D MA
$0.0871
Beta
0.00
Avg. Volume
375.15
EPS (Annual)
-$0.0474
P/B
0.63
$0.0202
Loading...
Loading...

About

Vaxil Bio Ltd. is an immunotherapy biotech company, which is engaged in the development of immunotherapies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. The firm's pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on July 26, 2006 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Vaxil Bio Ltd.?
What is the 52-week high for Vaxil Bio Ltd.?
What is the 52-week low for Vaxil Bio Ltd.?
What is Vaxil Bio Ltd. stock price today?
What was Vaxil Bio Ltd. stock price yesterday?
What is the PE ratio of Vaxil Bio Ltd.?
What is the Price-to-Book ratio of Vaxil Bio Ltd.?
What is the 50-day moving average of Vaxil Bio Ltd.?

Latest VXLLF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.